33.8 C
Vientiane
Sunday, June 8, 2025
spot_img
Home Blog Page 548

MEXC Unveils MNT Promotion Offering Up to $1 Million in Rewards

VICTORIA, Seychelles, March 31, 2025 /PRNewswire/ — MEXC, a leading global cryptocurrency exchange, has announced a groundbreaking partnership with Mantle (MNT) to launch an exclusive month-long trading campaign with a prize pool of up to $1,000,000, offering users an opportunity to earn substantial rewards.

MEXC Unveils MNT Promotion Offering Up to $1 Million in Rewards
MEXC Unveils MNT Promotion Offering Up to $1 Million in Rewards

The event presents a range of valuable opportunities for users:

  • Zero trading fees on MNT Spot and Futures markets, helping users reduce costs and optimize returns.
  • Up to 500% APR through MNT staking, offering one of the most competitive yields currently available.
  • Token rewards via Launchpool, where users can stake USDT, MX, or MNT to earn additional MNT tokens and exclusive benefits.

Additionally, users can join the Deposit & Trade campaign, designed with a low entry threshold—ideal for newcomers looking to explore the ecosystem. For seasoned traders, the Futures Trading Competition provides a platform to demonstrate their trading expertise, climb the leaderboard based on trading volume, and compete for a share of the $300,000 prize pool.

Event Overview

Period: March 31, 2025, 10:00 – April 30, 2025, 10:00 (UTC)

During the event period, users can participate in the following MNT-related activities on the platform by clicking on the links below.

Event 1: MNT trading (Spot and Futures) is available with zero trading fees.

Event 2: Users who deposit and trade MNT on the Spot market may qualify to share a pool of 113,340 MNT.

Event 3: MNT staking offers returns of up to 500% APR, subject to platform terms.

Event 4: A Futures Trading event allows participants to compete for a share of 300,000 USDT in bonus rewards.

Event 5: The MNT Launchpool enables users to stake selected tokens in exchange for a portion of 240,000 MNT in rewards.

As a pioneering Layer-2 scaling solution for Ethereum, Mantle uses Optimistic Rollup technology to lower transaction costs and improve network performance. This collaboration highlights MEXC’s leadership in backing innovative blockchain projects and its unwavering commitment to offering users diverse, cutting-edge trading opportunities, lowering costs and helping them maximize their potential returns.

Looking ahead, MEXC is committed to continuously enhancing the trading experience by introducing innovative features, expanding user opportunities, and launching new initiatives aligned with the dynamic nature of the cryptocurrency market.

For further details on the event, please see the official announcement.

About MEXC

Founded in 2018, MEXC is committed to being “Your Easiest Way to Crypto.” Serving over 34 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.

MEXC Official Website X Telegram |How to Sign Up on MEXC

Risk Disclaimer:

The information provided in this article regarding cryptocurrencies does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, the fundamentals of projects, and potential financial risks before making any trading decisions.

Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement Ingredients

SINGAPORE, March 31, 2025 /PRNewswire/ — Allozymes, a leader in protein engineering, and Bonumose, a leader in innovative enzyme combinations enabling the production of high-volume, healthy, naturally occurring monosaccharides from commodity feedstocks such as starch and sugar, announce the preliminary results of improvements to key enzymes for Bonumose’s ingredient production process.

Bonumose enzyme breakthroughs include unique combinations converting plant-based starch and other commodities in highly energetically favorable (high yield, high purity) production. Allozymes is optimizing key enzymes in the pathway to meet large-scale production specifications. The collaboration includes Allozymes’ cutting edge microfluidics-based protein engineering platform to achieve what was previously thought impossible: analyzing up to 20 million enzyme variants a day, delivering superior success rates, and dramatically reducing development timelines for novel enzymes.

“Optimizing enzymes for industrial-scale production requires precision, speed, and innovation, and our collaboration with Bonumose exemplifies this,” said Akbar Vahidi, Chief Technology Officer of Allozymes. “By leveraging our microfluidics-based protein engineering platform, we have been able to rapidly enhance key enzymes, significantly improving the process efficiency and scalability. The early results are promising, and we are confident that this partnership will unlock new possibilities in sustainable and cost-effective ingredient production.”

Dr. Daniel Wichelecki, Bonumose’s Chief Scientific Officer and Co-Founder, states, “Our mission is to produce healthy food and supplement ingredients in a low-cost, scalable production process. Our development collaborator Allozymes has shown promising results in the initial phases of our collaboration. We are on track and confident to meet our developmental objectives.”

The companies are pleased with the important milestone in both companies’ agenda of leveraging the use of enzymes to accelerate timelines and meet ambitious targets for producing beneficial ingredients to meet global needs for healthy food, dietary supplements, and other important categories.

“Our goal is to drive the future of sustainable food ingredient production through enzyme innovation,” said Akbar Vahidi. “Our collaboration with Bonumose is a critical part of this mission and we aim to demonstrate a successful model on how Allozymes enables innovation in the food ingredient market. With our unique platform, we are confident that we’ll continue to reduce development timelines and enhance performance, setting a new benchmark in the industry.”

About Allozymes

Allozymes is a biotechnology company that stands out in the bio-engineering sector with its proprietary ultra-high throughput microfluidics platform for the rapid and cost-effective development of enzymes, microbes, and biomanufactured ingredients. This technology sets a new standard for innovation and sustainability, enabling the development of robust biosolutions across various sectors. By leveraging its ultra-high screening power, Allozymes aims to build the world’s largest enzyme data library, addressing both current and future needs for advancing the bioeconomy.

Learn more at www.allozymes.com.

About Bonumose

Bonumose is a later-stage startup food ingredient and enzyme innovation company based in Albemarle County, Virginia, United States. Bonumose is supported by strategic investors, “food for health”-focused institutional investors, and a network of global collaboration partners across the value chain. Bonumose developed and patented the Bonumose® method for continuous production of high-purity tagatose and other good-for-you ingredients from abundant, plant-based feedstocks. Beyond sugar alternatives, Bonumose also has solutions for dietary supplements, crop protection, animal nutrition, and other globally significant industries. Bonumose operates with a philosophy of Business as a Moral Imperative and believes in the power of market incentives to solve intractable problems. Bonumose’s tagatose is certified/verified as Prebiotic, Ketogenic, Non-GMO, Plant-Based, Vegetarian, Kosher and Halal.

PXPay Plus and J.P Morgan Asset Management Taiwan Join Forces to Launch Industry-First Direct Fund Dividend Direct Deposit into E-Wallet Accounts

Endless Growth of Wealth: Reinvest Dividends into Micro-Investment Funds

TAIPEI, March 31, 2025 /PRNewswire/ — “Digital Hen” is a fund investment service jointly launched by PXPay Plus and Fund swap, integrating payment and investment functions. It is designed for beginner investors and budget-conscious individuals, allowing them to invest while they spend. The service offers two investment options: “Spare Change Saving” and “Regular Saving.”

Chairman of J.P Morgan Asset Management Taiwan-Henry Tong & General Manager of PXPay Plus-Kennith Yu
Chairman of J.P Morgan Asset Management Taiwan-Henry Tong & General Manager of PXPay Plus-Kennith Yu

Since its launch, it has achieved impressive results, gaining nearly 10,000 new users in Q4 2024 compared to Q3. On average, Digital Hen users have seen a return of approximately 10.9% (investment always carries risks; fund investments may gain or lose value; please read the prospectus carefully before subscribing). This service also makes it easier for beginner investors to build their wealth.

Following the launch of the “Digital Hen” service, PXPay Plus is once again expanding its footprint in financial innovation! Today (27th), PXPay Plus announced a partnership with J.P Morgan Asset Management Taiwan, a global leader in asset management, to launch a new service integrating  e-wallet with asset management. This service allows users to flexibly utilize their fund dividend earnings, enhancing daily convenience and quality of life while achieving their ideal financial goals.

With this innovative service, investors can have their fund dividends deposited directly into their PXPay Plus account balance, which can then be used for daily expenses. Additionally, by participating in designated promotional campaigns, users can earn “PXPay Plus Points” (1 PXPay Plus Point = 1 TWD, which can be redeemed for purchases). Alternatively, they can leverage the “Digital Hen” service to allocate small amounts of change into investments, reducing financial risks through diversification.

This service not only makes wealth management easier but also enables smarter spending! It offers investors a more flexible and diverse approach to asset utilization, creating a new experience in both financial management and payments.

※ Investment involves risks. Fund investments may result in gains or losses. Please read the fund prospectus carefully before making any investment decisions.※

First Ever in the Industry: Fund Dividends Deposited Directly into E-Wallet Accounts

J.P Morgan Asset Management Taiwan has been deeply rooted in the local market for 40 years and was the first foreign asset management company in Taiwan to offer online fund trading. By providing a diverse range of financial products and services, it integrates quantitative data with qualitative expertise to ensure clients benefit from convenient financial solutions.

Henry Tong, Chairman of J.P Morgan Asset Management Taiwan, emphasized that “products” and “customers” are the two core values of the company. Recognizing the growing demand for fund dividends, J.P Morgan Asset Management Taiwan has partnered with PXPay Plus to launch an innovative service, “Dividend Deposit into PXPay Plus” This new financial solution integrates PXPay Plus as one of the fund dividend deposit channels, allowing dividends to be directly credited to PXPay Plus accounts. This enhances capital utilization efficiency and offers dividend fund investors an additional option to use their earnings for daily expenses.

General Manager of PXPay Plus, Kennith Yu, highlighted that J.P Morgan Asset Management Taiwan is a globally trusted investment partner that stays ahead of market trends. Through this collaboration, PXPay Plus aims to achieve three key objectives: First, to attract more new users. Secondly, increase users’ consuming power to raise the transaction volume, since they have deposited their fund dividends into PXPay Plus wallet. Last of all, foster more cross-industry cooperation, creating opportunities to develop a more diverse financial platform. 

9 Funds Eligible for “Dividend Deposit to PXPay Plus” – Earn PXPay Plus Points with Qualifying Purchases!

To celebrate the launch of its new financial service, PXPay Plus is offering a special reward program for users. From April 1 to December 31, 2025, PXPay Plus members who are also users of the J.P Morgan Asset Management Taiwan DIRECT investment platform, who participate in the “Dividend Deposit to PXPay Plus” program and have at least one successful dividend deposit into a given month can earn  500 PXPay Plus Points by making a single purchase of NTD 500 or more using PXPay Plus in the following month.(This offer applies only to domestic J.P Morgan Asset Management Taiwan funds) Each user can receive a maximum of 500 PXPay Plus Points per month, up to 4,000 PXPay Plus Points throughout the campaign period.

For Example:

Scenario A:Hu-Li(The mascot of PXPay Plus) subscribes to a designated J.P Morgan Asset Management Taiwan fund before 4:00 PM on April 7, 2025, and links  their PXPay Plus account to receive fund dividends. In April 2025, the fund dividends are successfully credited to their PXPay Plus account. On May 2, 2025, Hu-Li makes a single purchase of NTD 568 at RT-Mart using PXPay Plus and receives 500 PXPay Plus Points as a reward.

Scenario B- Pang-P(Mascot of PXPay Plus) previously subscribed to a designated J.P Morgan Asset Management Taiwan fund and updated their dividend deposit method to PXPay Plus before March 31, 2025. In April 2025, the fund dividends are successfully credited to their PXPay Plus account. On May 5, 2025, Pang-P makes a single purchase of NTD 888 at RT-Mart using PXPay Plus,  Pang-P then receives 500 PXPay Plus Points as a reward. On the other hand, if users who do not receive fund dividends in April 2025 will not be eligible for the reward in May.)

Looking to  the future, this collaboration marks the beginning of a long-term partnership between PXPay Plus and J.P Morgan Asset Management Taiwan. Both companies aim to develop more innovative financial services, making fintech solutions accessible across different social sectors while enhancing platform competitiveness and market influence. Furthermore, PXPay Plus and J.P Morgan Asset Management Taiwan will continue to offer diverse and customized financial management and payment services, helping users achieve long-term financial goals while  creating a smarter, more convenient financial lifestyle.

Attachment 1

Promotion Period: 2025 April 1st to 2025 December 31st

Eligible Participants: This promotion is open to all PXPay Plus members who are also J.P Morgan Asset Management Taiwan DIRECT investment platform customers at the time of cashback calculation.

Promotion Details:

  • How to participate:

Log in to J.P Morgan Asset Management Taiwan DIRECT: PXPay Plus members must log in to the J.P Morgan Asset Management Taiwan DIRECT investment platform. Link the  Fund Dividend to PXPay Plus account, set up the deposit of domestic fund dividends to the PXPay Plus wallet. After identity verification and successful linking, the PXPay Plus membership number will appear in the fund account information under “My Account” > “Withdrawal/Deposit Account” > “Dividend Deposit Bank/Account”. : When a J.P Morgan Asset Management Taiwan domestic fund reaches the distribution threshold for the current month, the dividend will be credited to the PXPay Plus wallet.

  1. Only domestic J.P Morgan Asset Management Taiwan funds qualify for the dividend deposit to PXPay Plus accounts. If the fund is an international J.P Morgan Asset Management Taiwan fund, the dividend will be credited to the previously set bank account, and the user will not be eligible for this event.
  2. If a fund does not reach the distribution threshold for dividends in a given month, the dividend will not be credited to PXPay Plus, and the user will not be eligible for the event’s rewards. Please refer to the fund prospectus for the specific distribution threshold.
  3. You can view dividend deposit records in the PXPay Plus App under “My” > “Transaction Records”.
  • Boosting spending power:

Once the user  qualifies for the event, they can earn 500 PXPay Plus Points by making a single purchase of NTD 500 or more in the following month. Eligible purchases can be made with your PXPay Plus balance account, linked bank account, or linked credit card, including payments for domestic and international purchases.

The 500 PXPay Plus Points promotion points will be awarded starting in May 2025. Each customer can receive the reward once per month, up to 8 times during the event period.. The final month for receiving rewards is December 2025. A total of 5,000,000 PXPay Plus Points will be distributed, allocated on a first-come, first-served basis, until the total allocation is exhausted..

Example 1:

Your J.P Morgan Asset Management Taiwan domestic fund’s dividend is successfully credited to your PXPay Plus account in April (qualifying for the event). On May 3, 2025, you make a NTD 550 purchase with PXPay Plus wallet (meeting the NTD 500 minimum), and you will immediately receive 500 PXPay Plus Points. If you make another purchase on May 10, 2025, the reward will not be issued again in May as you are only eligible for one reward per month.

Example 2:

Your J.P Morgan Asset Management Taiwan domestic fund’s dividend is successfully credited to your PXPay Plus account in mid-April (qualifying for the event). If you make a purchase of NTD 600 on April 28, 2025, you will not receive the reward because the reward is applicable to purchases made in the month following the dividend deposit.The PXPay Plus Points will be issued by  PXPay Plus Co., Ltd., and the event is concurrent with other PXPay Plus promotions.

  • This collaboration with J.P Morgan Asset Management Taiwan is limited to fund dividends being deposited into PXPay Plus. Users cannot use PXPay Plus to purchase J.P Morgan Asset Management Taiwan funds, nor can they use PXPay Plus to make fund subscriptions or redemptions. Fund subscriptions and redemptions must be made through the J.P Morgan Asset Management Taiwan DIRECT platform.

About PXPay Plus

PXPay Plus, an e-wallet brand founded and 100% fully owned by the PX Mart Group. In June of 2021, PXPay Plus obtained licenses and approval for operating electronic payment related business from the FSC (Financial Supervisory Commission) in Taiwan. Continuing the company culture of the PX Mart group, building a delightful company environment for everyone. With the launch of PXPay Plus, users can now enjoy enhanced wallet features, providing a seamless and secure payment experience.

Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women

Sensoril® Ashwagandha is among Kerry’s portfolio of solutions tailored to meet women’s unique health needs  

SINGAPORE, March 31, 2025 /PRNewswire/ — Sensoril® ashwagandha — a science-backed ingredient by Kerry Group — has been shown to support quality of life for women post menopause, according to a new clinical study.

With the potential for women to spend up to 40% of their life post menopause, it is crucial those years are enjoyable.1 This recently published study validates Sensoril’s unique ability to support symptom management and quality of life in women post menopause, at as low as 250mg/day.

This research builds on the existing 14 scientifically backed studies that show the natural ingredient is a safe and effective solution to support overall health.

Hormonal changes associated with menopause can lead to negative symptoms like hot flashes, mood swings, and sleep disturbances. Approximately 80% of women experience these symptoms, making it a common but typically overlooked or ignored aspect of women’s health.2 In Asia Pacific, 64% of women experience pre-menopausal symptoms that impact their emotional health and 62% who are perimenopausal, menopausal or post-menopausal say they would be interested in nutritional supplements that help them manage their symptoms.3

Despite the frequency of these symptoms, the impact of menopause on ageing has not been considered widely in research, leading to gaps in women’s healthcare.4 With one billion women estimated to be experiencing menopause in 2025, these shortcomings must be addressed.5

Increasingly, the use of herbal, plant-based treatments for managing menopausal symptoms has been gaining popularity as many women seek more natural alternatives to hormone replacement therapy. Sensoril, a unique, standardised, synergetic combination of the ashwagandha root and leaf, directly meets this need. With demonstrated efficacy, Sensoril can be a key, natural ingredient integrated into solutions specifically targeted toward women. 

Participants in the clinical study reported decreases across key known menopause symptoms, including:

  • 24% decrease in presence and severity of vasomotor symptoms such as hot flashes, sweating, and night sweats. 
  • 16% decrease in presence and severity of psychosocial symptoms such as poor memory, anxious feelings, lower productivity, dissatisfaction with personal life, and more.  
  • 14% decrease in presence and severity of physical symptoms related to sleep, fatigue, strength, stamina, energy, appearance, aches and pains, and more.
  • 13% decrease in presence and severity of changes in sexual health such as decrease in sexual desire, intimacy avoidance, and vaginal dryness.

“Women are seeking support for their wellbeing where their specific female health needs are understood and met with the right product at the right time,” said Dr. Monica Maria Olivares, RDA Director, Women & Infant Health at Kerry. “This study further supports the current and extensive research naming Sensoril a safe and effective solution. Driving progress in women’s health is of vital importance to us at Kerry, which is why we have curated a suite of naturally sourced and clinically studied ingredients that support women across every life stage. “

KEENON Robotics Marks a New Milestone with the Unveiling of the Humanoid Robot XMAN-R1 and the Latest KLEENBOT Additions

SHANGHAI, March 31, 2025 /PRNewswire/ — KEENON Robotics, a global leader in autonomous service robotics, officially introduces the XMAN-R1 humanoid robot alongside the latest KLEENBOT models—C40, C55, and C20. This introduction marks a significant milestone in KEENON’s development of multi-form service robotics solutions, reinforcing its ability to meet diverse and complex business needs.

From humanoid robots designed to interact with people to a full-scenario cleaning robotics lineup, these latest offerings reflect KEENON’s ongoing efforts to enhance service capabilities across industries.

XMAN-R1: Engineered to Serve

KEENON Robotics presents XMAN-R1, a humanoid robot developed to interact with people and collaborate with other KEENON robots, such as the DINERBOT T10, KLEENBOT C30, and KEENON S100. It is designed to enhance task coordination and expand service possibilities across a wide range of commercial settings, with continued advancements expected to refine its integration with KEENON’s robotic solutions.

With ongoing advancements in intelligent learning and task optimization, XMAN-R1 is expected to continuously improve coordination with other robotic solutions and adapt to changing service requirements.

KEENON XMAN-R1 & DINERBOT T10
KEENON XMAN-R1 & DINERBOT T10

Advancing Cleantech Solutions with the Latest KLEENBOT Models

With the addition of the C40, C55, and C20, the KLEENBOT series now provides solutions for every environment. These new releases elevate KEENON’s cleaning robotics offerings into a comprehensive, all-scenario lineup, supporting businesses in maintaining high hygiene standards efficiently and reliably.

KEENON KLEENBOT: Smart Cleantech Solutions for Every Environment
KEENON KLEENBOT: Smart Cleantech Solutions for Every Environment

The KLEENBOT C40, with a 65 cm minimum pass-through width, is designed for small to medium-sized commercial spaces, handling surfaces like short-pile carpets, tiles, wood, and marble. Its 40 cm scrubbing and vacuuming width ensures efficient cleaning in tight areas. The triple-brush system completes sweeping and scrubbing in one step, followed by fast drying after scrubbing. Equipped with 10 detection components, it navigates complex environments smoothly. Maintenance is simplified with a one-step dust box and dirty water tank swap, enabling quick vacuum-scrub mode switching. Additionally, key components like roller brushes and suction bar can be easily disassembled for efficient upkeep. The C40 is compatible with KEENON’s App and Cloud Platform for real-time monitoring and task scheduling.

Designed for large commercial spaces, the KLEENBOT C55 features a 55 cm cleaning width and a high-capacity water tank, making it well-suited for extended operations. The triple-brush system effectively removes tough stains, while its 11.6-inch display provides real-time status updates. With support for multi-robot collaboration, automatic recharging, and resume-cleaning functions, it enhances operational efficiency in venues such as malls and airports.

With a 35 cm slim body, the KLEENBOT C20 can access dust accumulation spots, making it ideal for compact spaces like convenience stores and offices. It operates with a dual-tank system, ensuring clean water is used for every cleaning task while dirty water is automatically collected. A modular design enables quick removal and replacement of components like side brushes and dust box, simplifying maintenance.

With embodied intelligence and advanced AI, the XMAN-R1 and KLEENBOT series continue to enhance KEENON’s robotics ecosystem, driving multi-form service robotics and comprehensive cleaning solutions. These innovations are designed to address the evolving needs of industries like retail, hospitality, healthcare, and industrial sector while positioning KEENON for future advancements in automation, intelligent service, and smarter operational efficiencies.

For more information, please contact global@keenon.com or visit https://www.keenon.com/

About KEENON Robotics

A global leader in commercial service robots and solutions, KEENON Robotics has been at the forefront of the advanced service robot market since 2010. Harnessing cutting-edge technologies in robotics and cloud computing, the company is trusted by businesses worldwide. KEENON Robotics is dedicated to creating value, fostering innovation, and contributing to industry growth across various sectors.

Vientiane Authorities Announce Regulations for Lao New Year Celebrations

Buddha (Photo: JCLao)

The Ministry of Public Security has released regulations for the upcoming Lao New Year, which will be celebrated from April 14 to 16. These measures aim to ensure public safety and orderly celebrations throughout Vientiane Capital.

Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing

SUZHOU, China, March 31, 2025 /PRNewswire/ — Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of nearly RMB 300 million, a sharp 44% year-over-year (YoY) increase, signaling the initial success of its globalized full-industry-chain strategy and positioning it to become the most innovative player in the global assisted reproduction field. As societies grapple with fertility challenges and high childcare costs, China has integrated assisted reproductive services into its national healthcare system and accelerated childcare subsidy policies. Concurrently, the U.S. White House issued an executive order to strengthen fertility healthcare, mandating commercial insurance plans to cover in vitro fertilization (IVF) treatments and expanding fertility welfare policies. 

44% Revenue Growth: Building a Full-Industry-Chain Ecosystem in Reproductive Health 

Against a backdrop of heightened policy support for fertility, the assisted reproduction industry has entered a strategic growth phase. As a leader in the field, Basecare Medical has leveraged its first-mover advantages in genetic testing, embryo culture, andrology diagnostics, and cryopreservation to establish a closed-loop technological ecosystem across the entire assisted reproduction value chain, emerging as one of China’s few industrial-scale benchmark enterprises. 


Basecare’s 2024 financial results highlight accelerated growth and a maturing product pipeline. The company reported revenue of RMB 299 million (up 44% YoY), gross profit of RMB 136 million (up 49% YoY), and a 1.62 percentage point improvement in gross margin to 45.54%, driven by differentiated growth across core business segments. 

Genetic Lab Section: PGT Technology Matrix as Core Barrier

The genetic testing division generated RMB 160 million in revenue (up 6% YoY), with PGT-related growth sustaining a 15% rate and the ECS project surging 56%. The recent approval of the DA5000 high-throughput sequencer marked another milestone in China’s 14th Five-Year Plan R&D initiatives. Basecare’s self-developed PGT-A kit, holding China’s first Class III innovative medical device certification, retains its first-mover edge. The PGT-M kit has completed clinical registration, poised to fill the domestic gap in single-gene disorder testing, while the PGT-SR kit is in final clinical stages, expected to complete the “PGT-A+M+SR” product line by 2025. 

Embryo Lab: Localization Penetrates High-End Markets  

Revenue in the embryo lab segment soared 161% YoY to RMB 126 million. The flagship GERI time-lapse incubator, featuring the world’s only humidity-compatible time-lapse imaging system, saw explosive growth with China sales multiplying sixfold and 42 units installed in 2024. With domestic registration expected in H1 2025, production costs are projected to drop over 30%, complemented by breakthroughs in localized Gems embryo culture media. Basecare is targeting a RMB 1 billion end-market opportunity (Frost & Sullivan data) to deepen import substitution. 

Andrology & Cryopreservation: AI Redefines Industry Standards

The andrology and cryostorage division achieved breakthroughs via AI innovation. The BKA210 intelligent sperm analyzer, China’s first AI-powered real-time live sperm analysis system with regulatory approval, revolutionizes diagnostics with full assessment in three minutes. The BSG800 ultra-low temperature storage system, deployed at Guangdong Provincial Reproductive Hospital’s smart sperm bank, achieved zero-error sample storage. Basecare also formed an AI sperm detection multi-center research alliance with 18 top institutions, offering end-to-end solutions from male fertility testing to preservation. 

By synergizing “hardware + reagents + AI systems,” Basecare is evolving from a product supplier to a fertility health ecosystem platform. Its full-industry-chain capabilities, turbocharged by policy tailwinds and technological upgrades, reinforce its leadership in China’s localization wave. 


From “Made in China” to “Global Intelligent Manufacturing” 

Basecare’s breakthroughs extend beyond domestic dominance, positioning it as a global intelligent manufacturing exemplar through cross-border innovation.  

Global Supply Chain: APEC as Growth Engine

In 2024, Basecare’s Thailand production base commenced operations, enabling localized production of GERI incubators and Gelida 47 smart liquid nitrogen tanks to serve Southeast Asia and South America. Partnering with Singapore’s Rhea Labs, the company launched an integrated IVF clinic solution covering equipment, consumables, and training. With manufacturing hubs in Suzhou, Melbourne, and Thailand, Basecare’s cross-time-zone supply chain now serves over 1,000 medical institutions across 30 countries. Overseas revenue contributions rose to 35% in 2024, with Europe, North America, and Asia-Pacific sales growing 27%, 19%, and 5% YoY, respectively. Aligning with China’s Belt and Road Initiative and Thailand’s Eastern Economic Corridor, Basecare is deepening global industrial integration through technology exports and localized production. 

AI-Driven Fertility: Reshaping Assisted Reproduction

The EEVA embryo assessment system, integrated into GERI incubators and backed by over 100,000 embryo datasets, became the first FDA-approved AI tool to enhance top-tier embryo selection efficiency by 40%. Leveraging data from subsidiary Genea Biomedx’s global IVF clinics, Basecare is building an AI matrix for embryo, sperm, and oocyte analysis, aiming to launch an AI-powered embryo transfer planning system. The company is advancing toward becoming the world’s first “AI + Reproductive Health” platform, pushing the boundaries of intelligent assisted reproduction. 


Outlook: Bridging the Valuation Gap

As fertility issues rise to national policy agendas, Basecare, with its full-industry-chain capabilities, stands at the forefront of China’s pro-fertility policy. However, market valuations lag its potential: as of March 28, its TTM price-to-sales ratio of 3.66x remains in the lower historical range, undervaluing its technological moat and global positioning. 

With accelerating commercialization of innovations and IVF’s inclusion in public insurance, Basecare—already operating in over 30 countries—is poised to capitalize on rising IVF adoption and redefine global industry dynamics. As a trailblazer in China’s high-end medical manufacturing, its journey from local champion to global disruptor merits close watch.


 

ATRenew Announces Grand Opening of Paijitang Flagship Store in Shenzhen

SHANGHAI, March 31, 2025 /PRNewswire/ — ATRenew Inc. (“ATRenew” or the “Company”) (NYSE: RERE), a leading technology-driven platform for pre-owned consumer electronics transactions and services in China, today launched the grand opening of its Paijitang flagship store in Shenzhen. Located in Huaqiangbei, the country’s premier electronics trade hub, the store features nearly 10,000 professionally inspected smartphones, setting a new benchmark for transparency in the second-hand electronics market.

Paijitang, ATRenew’s B2B trading platform, provides standardized and efficient transaction services to over 850,000 small and medium-sized businesses across China. The launch of its offline store enhances the platform’s seamless online-to-offline integration, driving industry standardization and expansion.

“As a front-end distribution center, the Paijitang flagship store operates on a ‘warehouse-to-retail model,’ which enables buyers to browse inventory, inspect devices, and complete purchases onsite—helping businesses reduce inventory costs and minimizing logistics delays by 3 to 5 days,” said Mr. Kerry Xuefeng Chen, Founder, Chairman, and CEO of ATRenew. “By offering a compliant and efficient sourcing solution, we are committed to fostering the long-term, sustainable growth of the pre-owned electronics industry.”

About ATRenew Inc.

Headquartered in Shanghai, ATRenew Inc. operates a leading technology-driven pre-owned consumer electronics transactions and services platform in China under the brand ATRenew. Since its inception in 2011, ATRenew has been on a mission to give a second life to all idle goods, addressing the environmental impact of pre-owned consumer electronics by facilitating recycling and trade-in services, and distributing the devices to prolong their lifecycle. ATRenew’s open platform integrates C2B, B2B, and B2C capabilities to empower its online and offline services. Through its end-to-end coverage of the entire value chain and its proprietary inspection, grading, and pricing technologies, ATRenew sets the standard for China’s pre-owned consumer electronics industry. ATRenew is a participant in the United Nations Global Compact, and adheres to its principles-based approach to responsible business.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Among other things, quotations in this announcement, contain forward-looking statements. ATRenew may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about ATRenew’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: ATRenew’s strategies; ATRenew’s future business development, financial condition and results of operations; ATRenew’s ability to maintain its relationship with major strategic investors; its ability to facilitate pre-owned consumer electronics transactions and provide relevant services; its ability to maintain and enhance the recognition and reputation of its brand; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in ATRenew’s filings with the SEC. All information provided in this press release is as of the date of this press release, and ATRenew does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact
In China:
ATRenew Inc.
Investor Relations
Email: ir@atrenew.com